Key Performance
More- Earnings Score: N/A
- Momentum Score: 57
- True Yield: N/A
- Financial Health Score: N/A
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
LifeStance Health Group Announces Pricing of Secondary Public Offering
LifeStance Health Group (Nasdaq: LFST) announced the pricing of a secondary public offering of 35 million shares at $8.15 per share. The company will not receive proceeds from the offering but has agreed to repurchase 6 million shares from the underwriter. The offering is expected to close on May 12, 2026, with J.P. Morgan serving as the underwriter.
05/07/2026, 10:18 PM • GlobeNewswire
LifeStance Reports First Quarter 2026 Results
LifeStance Health Group (NASDAQ: LFST) announced Q1 2026 results with revenue of $403.5 million, up 21% year-over-year, and net income of $14.2 million compared to $0.7 million in Q1 2025. The company increased its clinician base by 11% to 8,349 and raised full-year 2026 guidance for revenue, center margin, and adjusted EBITDA. The company also announced an outcomes study showing approximately 75% of 180,000 patients reported clinically significant improvement in anxiety and depression.
05/07/2026, 6:00 AM • GlobeNewswire
A LifeStance Health Insider Sold Nearly 70,000 Shares. Here's What That Means for Investors.
LifeStance Health Group director Robert Bessler sold 69,899 shares worth approximately $492,000 on April 23-24, 2026. The sale represented only 2.47% of his total holdings, with over 2.7 million shares retained indirectly. Analysts view this as non-concerning given Bessler's substantial remaining stake and the company's strong 2025 performance, which included 14% revenue growth and a turnaround to profitability.
04/29/2026, 9:32 AM • The Motley Fool
The emotional counseling service market is projected to grow from $4.72 billion in 2025 to $21.21 billion by 2030, with a CAGR of 35%. Growth drivers include increased digital therapy adoption, rising mental health infrastructure investments, employer-sponsored services expansion, and focus on adolescent mental health. Leading companies are leveraging AI-based tools and tele-counseling platforms to enhance accessibility and personalized care.
02/23/2026, 4:51 AM • GlobeNewswire
The grief counseling market is projected to grow from $3.67 billion in 2025 to $5.83 billion by 2030 at a CAGR of 9.7%. Growth is driven by increased mental health awareness, expansion of digital support platforms, telehealth adoption, and rising demand for accessible bereavement care. Key players include Cleveland Clinic, LifeStance Health, VITAS Healthcare, and Talkspace.
02/23/2026, 4:49 AM • GlobeNewswire
Presidio Appoints Paula Cipollone Chief Transformation Officer
Presidio appointed Paula Cipollone as Chief Transformation Officer to lead strategic operations and drive AI-powered transformation, focusing on streamlining operations and enhancing customer engagement.
09/30/2025, 10:00 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 06/22/2026
Company Profile
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.